What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 6.8% in the morning session after Barclays boosted ...

The past six months have been a windfall for 10x Genomics’s shareholders. The company’s stock price has jumped 116%, setting ...

A newly developed open-source tool designed for rigorous reanalysis of genomic data is highly effective at detecting new rare disease diagnoses. The tool's ability to frequently and automatically ...

The era of predictive genomics is rapidly reshaping how we think about disease, risk and lifelong health. Recent advances in whole-genome sequencing have equipped clinicians with insights into our ...

Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced a research collaboration with Cleveland Clinic, a nonprofit ...

Metabolon, Inc., the global leader in metabolomics solutions advancing life science research, diagnostics, therapeutics, and precision medicine, today announced the successful completion and delivery ...

X Genomics (TXG) stock climbed 3.8% after revealing a Cleveland Clinic partnership for bladder cancer research using Flex ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

On June 8, 2026, Google DeepMind, Google.org, and the Wellcome Sanger Institute announced a five-year artificial intelligence ...

Bionano Genomics remains under watch as market volatility raises attention on clinical adoption, funding discipline, and ...

A member of Joanna Kelley's lab talks with symposium participants about a project to sequence the genomes of North American brown bears. Photos by Carolyn Lagattuta. California is losing its living ...

If you are a bioinformatics platform lead, an ML infrastructure engineer, or a genomics budget owner who is now running ...